| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Sagan Paul serves as a Director at MRNA and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 1 buy and 5 sells. Those positions are worth an estimated $9.9M at current prices.
The biggest single holding is MRNA (~$9.9M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 29,370 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | MRNA Moderna, Inc. | Director | Buy | 31,620 | $31.76 | $1,004,251.20 | +11.3% | -10.6% | +64.6% | |
| Oct 13, 2021 | MRNA Moderna, Inc. | Director | Sell | 2,250 | $314.90 | $708,525.00 | -13.1% | -31.1% | -58.1% | |
| Nov 9, 2018 | AKAM Akamai Technologies Inc | Director | Sell | 55,500 | $70.46 | $3,910,530.00 | -48.2% | - | - | |
| Aug 7, 2018 | AKAM Akamai Technologies Inc | Director | Sale+OE | 39,092 | $75.19 | $2,939,327.48 | -25.3% | - | - | |
| Jul 24, 2018 | AKAM Akamai Technologies Inc | Director | Sale+OE | 39,100 | $79.51 | $3,108,841.00 | -25.3% | - | - | |
| Jul 10, 2018 | AKAM Akamai Technologies Inc | Director | Sale+OE | 39,100 | $76.09 | $2,975,119.00 | -25.3% | - | - |